Terms: = Head and neck cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716 AND Treatment
29 results:
1. WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/jak1/STAT3 signaling.
Huang Q; Xiao Y; Lan T; Lu Y; Huang L; Zheng D
Int J Oral Sci; 2024 Jan; 16(1):7. PubMed ID: 38246919
[TBL] [Abstract] [Full Text] [Related]
2. DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β.
Zhou L; Yao N; Yang L; Liu K; Qiao Y; Huang C; Du R; Yeung YT; Liu W; Cheng D; Dong Z; Li X
Cell Rep; 2023 May; 42(5):112445. PubMed ID: 37141098
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells.
Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
[No Abstract] [Full Text] [Related]
4. STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in head and neck cancer.
Qureshy Z; Li H; Zeng Y; Rivera J; Cheng N; Peterson CN; Kim MO; Ryan WR; Ha PK; Bauman JE; Wang SJ; Long SR; Johnson DE; Grandis JR
Clin Cancer Res; 2022 Nov; 28(21):4737-4746. PubMed ID: 35929989
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of ribophorin II is required for viability of nasopharyngeal cancer cells by regulating jak1/STAT3 activation.
Wang B; Liu W; Jiang X; Li J; Hu X; Li L; Gu Q
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):471-477. PubMed ID: 34184962
[TBL] [Abstract] [Full Text] [Related]
6. Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment.
Zhao D; Chen J; Wang Y; Zhang L; Zhang J; Zhang W; Fan J; Li J; Zhan Q
Mol Carcinog; 2021 Jul; 60(7):481-496. PubMed ID: 34018249
[TBL] [Abstract] [Full Text] [Related]
7. Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.
Setakornnukul J; Thephamongkhol K; Chaysiri P
Head Neck; 2020 Oct; 42(10):2801-2810. PubMed ID: 32542997
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of jak1/2-STAT3 and AKT/MDM2/p53 signaling pathways.
Gao J; Xia R; Chen J; Gao J; Luo X; Ke C; Ren C; Li J; Mi Y
Aging (Albany NY); 2020 Apr; 12(7):6240-6259. PubMed ID: 32276266
[TBL] [Abstract] [Full Text] [Related]
9. Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in head and neck Squamous Cell Carcinoma.
Lee JH; Rangappa S; Mohan CD; ; Sethi G; Lin ZX; Rangappa KS; Ahn KS
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31575007
[TBL] [Abstract] [Full Text] [Related]
10. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract] [Full Text] [Related]
11. Akt1 and jak1 siRNA based silencing effects on the proliferation and apoptosis in head and neck squamous cell carcinoma.
Vakili Saatloo M; Aghbali AA; Koohsoltani M; Yari Khosroushahi A
Gene; 2019 Sep; 714():143997. PubMed ID: 31348981
[TBL] [Abstract] [Full Text] [Related]
12. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract] [Full Text] [Related]
13. Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 asa candidate to predict metastases.
Upadhyay P; Gardi N; Desai S; Chandrani P; Joshi A; Dharavath B; Arora P; Bal M; Nair S; Dutt A
Oral Oncol; 2017 Oct; 73():56-64. PubMed ID: 28939077
[TBL] [Abstract] [Full Text] [Related]
14. Mechanisms of Resistance to Immune Checkpoint Antibodies.
Ramos RN; Piaggio E; Romano E
Handb Exp Pharmacol; 2018; 249():109-128. PubMed ID: 28315073
[TBL] [Abstract] [Full Text] [Related]
15. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
[TBL] [Abstract] [Full Text] [Related]
16. Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition.
Bonner JA; Trummell HQ; Bonner AB; Willey CD; Bredel M; Yang ES
BMC Cancer; 2015 Oct; 15():673. PubMed ID: 26458879
[TBL] [Abstract] [Full Text] [Related]
17. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
[TBL] [Abstract] [Full Text] [Related]
18. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.
Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN
Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226
[TBL] [Abstract] [Full Text] [Related]
19. Clinicobiological progression and prognosis of oral squamous cell carcinoma in relation to the tumor invasive front: impact on prognosis.
Sandu K; Nisa L; Monnier P; Simon C; Andrejevic-Blant S; Bron L
Acta Otolaryngol; 2014 Apr; 134(4):416-24. PubMed ID: 24628337
[TBL] [Abstract] [Full Text] [Related]
20. Overcoming cancer cell resistance to VSV oncolysis with jak1/2 inhibitors.
Escobar-Zarate D; Liu YP; Suksanpaisan L; Russell SJ; Peng KW
Cancer Gene Ther; 2013 Oct; 20(10):582-9. PubMed ID: 24030211
[TBL] [Abstract] [Full Text] [Related]
[Next]
